Paolo Bossi

Humanitas University — Italy

Medicine · Health Sciences

66h-index15.8kcitations661works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(327), Head and Neck Surgical Oncology(113), Oral health in cancer treatment(88), Lung Cancer Treatments and Mutations(81), Cancer Diagnosis and Treatment(76)

Publications657 total

Clinical and Patient-Reported Outcomes (PROs) in C-POST: A Phase 3 Trial of Adjuvant Cemiplimab Versus Placebo for High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
SKIN The Journal of Cutaneous Medicine·2025Open Access
ALMA platform: a Pan-cancer agnostic multi-modal liquid biopsy approach for enhanced MRD detection and therapy monitoring
The Journal of Liquid Biopsy·2025Open Access
MASCC/ISOO Clinical Practice Statement: management of oral complications of immunotherapy
Supportive Care in Cancer·2025· 2 citedOpen Access
A multicenter retrospective analysis of recurrent/metastatic nasopharyngeal cancer from non-endemic areas: Results in the pre-immunotherapy era
European Journal of Cancer·2025· 1 cited
1429P Activity of cytotoxic chemotherapy in recurrent and/or metastatic salivary glands: A multicenter retrospective study
Annals of Oncology·2025
1379P Genome wide copy number alterations in ctDNA as novel biomarker in head and neck squamous cell cancer (IDENTIFY Trial)
Annals of Oncology·2025
1658P Neoadjuvant plus adjuvant treatment with cemiplimab in surgically resectable, high risk stage III/IV (M0) cutaneous squamous cell carcinoma (NEO-CESQ): Biomarker analysis
Annals of Oncology·2025
1359P Real-world efficacy data of 1st line treatment in recurrent/metastatic head and neck squamous cell carcinoma in Italian and Spanish cohorts. The REALKEY study
Annals of Oncology·2025
1603MO Analysis of second primary cutaneous squamous cell carcinoma (CSCC) tumors (SPTs) reported during the C-POST trial, a randomized phase III study of adjuvant cemiplimab vs placebo (pbo) for high-risk CSCC
Annals of Oncology·2025
1660P Adjuvant cemiplimab for high-risk cutaneous squamous cell carcinoma: Evaluating dosing intervals in a phase III trial
Annals of Oncology·2025
Clarifying the consensus on laryngeal preservation strategies – Authors' reply
The Lancet Oncology·2025
1392P The impede phase II trial: Avelumab (A) in high-risk oral potentially malignant disorders (OPMDs) for prevention of malignant transformation
Annals of Oncology·2025
Adverse event profiles and management of cisplatin-based chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: a systematic review
Oral Oncology·2025· 2 citedOpen Access
The Multifaceted Role of Growth Differentiation Factor 15 (GDF15): A Narrative Review from Cancer Cachexia to Target Therapy
Biomedicines·2025· 3 citedOpen Access
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders
Oral Oncology·2025· 6 citedOpen Access
Current practices and challenges in the management of cancer-associated thrombosis: a survey of Italian oncologists
Frontiers in Oncology·2025· 1 citedOpen Access
Non-cisplatin concurrent agents plus definitive radiotherapy for locally advanced head and neck cancer: A network meta-analysis of randomized studies
Radiotherapy and Oncology·2025· 2 cited
Longitudinal assessment of plasma EBV-DNA in non-endemic EBV-related nasopharyngeal cancer (NPC): the LEA study
European Journal of Cancer·2025· 1 citedOpen Access
Selected laryngeal squamous cell carcinomas with laryngeal mobility impairment are suitable for curative larynx-preservation treatment
Oral Oncology·2025· 2 citedOpen Access
Supplementary Data 1 from INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
2025Open Access
page 1 of 33Next →

Frequent Co-authors

Lisa Licitra(23), Laura D. Locati(14), Federica Perrone(12), Cristiana Bergamini(10), Karis Kin Fong Cheng(9), Pasquale Quattrone(9), Ester Orlandi(8), Luigi Mariani(7), Silvana Pilotti(7), Elad Sharon(7), Barbara Cortelazzi(7), Roberta Granata(7), Rajesh V. Lalla(6), Vinisha Ranna(6), Anusha Vaddi(6), Abhishek Kandwal(6), Salvatore Lo Vullo(5), Salvatore Alfieri(5), Noam Yarom(4), Anura Ariyawardana(4)